A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer
Clinical trial NCT06406673 · UNKNOWN
Trial details
- NCT number
- NCT06406673
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2024-08-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.